Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.20p
   
  • Change Today:
      0.100p
  • 52 Week High: 64.50
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 476,890
  • Market Cap: £347.04m
  • RiskGrade: 119
  • Beta: 0.00

Latest ShareCast News

Alliance Pharma agrees to take-private deal

By Iain Gilbert

Date: Monday 10 Mar 2025

(Sharecast News) - Speciality drugmaker Alliance Pharma has agreed to be taken private in a deal valued at more than £360.0m.

Alliance Pharma FY profits seen in line with expectations

By Iain Gilbert

Date: Friday 31 Jan 2025

(Sharecast News) - International healthcare firm Alliance Pharma said on Friday that FY24 group profits would be in line with expectations despite a modest downturn in revenues.

DBAY Advisors to buy Alliance Pharma in £349.7m deal

By Michele Maatouk

Date: Friday 10 Jan 2025

(Sharecast News) - AIM-listed Alliance Pharma said on Friday that it has agreed to be bought by asset management firm DBAY Advisors in a £349.7m deal.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.20p
Change Today 0.100p
% Change 0.16 %
52 Week High 64.50
52 Week Low 29.35
Volume 476,890
Shares Issued 540.57m
Market Cap £347.04m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.84% below the market average68.84% below the market average68.84% below the market average68.84% below the market average68.84% below the market average
4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average
Price Trend
73.56% above the market average73.56% above the market average73.56% above the market average73.56% above the market average73.56% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average
Income Not Available
Growth
28.5% below the market average28.5% below the market average28.5% below the market average28.5% below the market average28.5% below the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-Apr-2025

Time Volume / Share Price
16:35 228,900 @ 64.20p
16:35 287 @ 64.20p
16:35 2,036 @ 64.20p
16:35 2,677 @ 64.20p
16:35 162 @ 64.20p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page